InspireMD Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/16/23
InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and WebcastGlobeNewsWire • 05/12/23
InspireMD Announces May 15th as New Date for First Quarter 2023 Financial Results and Corporate Business UpdateGlobeNewsWire • 05/05/23
InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) PlatformGlobeNewsWire • 05/01/23
InspireMD to Report First Quarter 2023 Financial Results on May 9, 2023, and Provide Corporate Business UpdateGlobeNewsWire • 04/27/23
InspireMD Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/30/23
InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business UpdateGlobeNewsWire • 03/02/23
InspireMD Announces Hiring of Medical Device Commercial Veteran Shane Gleason as General Manager of North America and VP of Global MarketingGlobeNewsWire • 02/14/23
InspireMD Announces Multiple Presentations Featuring CGuard EPS and its Novel MicroNet Mesh Covering at the 2022 VEITH SymposiumGlobeNewsWire • 11/15/22
InspireMD Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/08/22
InspireMD to Report Third Quarter 2022 Financial Results on November 8, 2022, and Provide Corporate Business UpdateGlobeNewsWire • 10/25/22
InspireMD Announces Presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) ConferenceGlobeNewsWire • 09/13/22
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product DevelopmentBusiness Wire • 09/08/22
InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
InspireMD Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/09/22
InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business UpdateGlobeNewsWire • 08/02/22
InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic AdvisorGlobeNewsWire • 07/14/22
InspireMD Provides Highlights from Recent Presentations and Live Case Transmission at LINC 2022GlobeNewsWire • 06/09/22